Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA190703 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Targeted molecular therapy has yielded remarkable outcomes in certain cancers, but specific therapeutic targets remain elusive for many others. As a result of two independent RNA interference (RNAi) screens, we identified pathway dependence on a member of the JAK tyrosine kinase family, TYK2, and its downstream effector STAT1 in T-cell acute lymphoblastic leukemia (T-ALL). Gene knockdown experiments consistently demonstrated TYK2 dependence in both T-ALL primary specimens and cell lines, and a small-molecule inhibitor of JAK kinase activity induced T-ALL cell death. Activation of this TYK2-STAT1 pathway in T-ALL cell lines occurs by gain-of-function TYK2 mutations or activation of IL-10 receptor signaling, and this pathway mediates T-ALL cell survival through upregulation of the anti-apoptotic protein BCL2. These findings indicate that in many T-ALL cases, the leukemic cells are dependent upon the TYK2-STAT1-BCL2 pathway for continued survival, supporting the development of molecular therapies targeting TYK2 and other components of this pathway. Human T-ALL cell line JURKAT cells were transduced with TYK2 (TYK2#2 or #3), STAT1 (STAT1#2 or #3) or control shRNAs (GFP and Luc). Experiment was done in biological duplicate ("dup1" and "dup2") . A total of 12 RNA samples (4 control, 4 TYK2 knockdown and 4 STAT1 knockdown) were used for microarray gene expression analysis.
2013-03-18 | E-GEOD-44652 | biostudies-arrayexpress
Project description:Gene expression profile of human T-ALL cell line JURKAT after TRIB2 knockdown
| PRJNA275673 | ENA
Project description:RNA-seq of human cancer cell line OVCA420* following TIGAR knockdown with shRNA
2025-01-23 | E-MTAB-7284 | ExpressionAtlas
Project description:Expression profiling of human medulloblastoma cell line ONS76 upon siRNA-mediated knockdown of KDM5A/LSD1
2025-01-24 | E-GEOD-43552 | ExpressionAtlas
Project description:Targeted molecular therapy has yielded remarkable outcomes in certain cancers, but specific therapeutic targets remain elusive for many others. As a result of two independent RNA interference (RNAi) screens, we identified pathway dependence on a member of the JAK tyrosine kinase family, TYK2, and its downstream effector STAT1 in T-cell acute lymphoblastic leukemia (T-ALL). Gene knockdown experiments consistently demonstrated TYK2 dependence in both T-ALL primary specimens and cell lines, and a small-molecule inhibitor of JAK kinase activity induced T-ALL cell death. Activation of this TYK2-STAT1 pathway in T-ALL cell lines occurs by gain-of-function TYK2 mutations or activation of IL-10 receptor signaling, and this pathway mediates T-ALL cell survival through upregulation of the anti-apoptotic protein BCL2. These findings indicate that in many T-ALL cases, the leukemic cells are dependent upon the TYK2-STAT1-BCL2 pathway for continued survival, supporting the development of molecular therapies targeting TYK2 and other components of this pathway.
2013-03-18 | GSE44652 | GEO
Project description:Transcription profiling by high throughput sequencing of Musashi1 and Musashi2 knockdown in human pancreatic cancer cell line MIA PaCa2
2025-01-24 | E-GEOD-75797 | ExpressionAtlas
Project description:Transcription profiling of human T cell leukaemia cell line Jurkat that were retrovirally transduced with constitutievely active forms of Notch to identify novel transcriptional targets of Notch signalling
2025-01-22 | E-MEXP-1744 | ExpressionAtlas
Project description:Transcriptome profile of human pancreatic beta cell line (EndoC-βH2 ) following knockdown of RFX6.
| PRJNA254207 | ENA
Project description:Expression data from MTDH knockdown in the Hec50co endometrial cancer cell line
2025-01-24 | E-GEOD-26134 | ExpressionAtlas
Project description:Gene expression in human endometrial cancer tissues and serous papillary endometrial cancer cell line, SPAC-1L, treated by STAT1-siRNA and/or IFN-gamma
2025-01-24 | E-GEOD-56026 | ExpressionAtlas